Company intelligence / Profile preview

Yaizu Suisankagaku Industry

Yaizu, Shizuoka, Japan

Ownership: Private
Employees: ~250
Development stage: Other

Overview

Yaizu Suisankagaku Industry (YSK) is a leading Japanese manufacturer of functional food ingredients and pharmaceutical precursors derived from marine resources. Their primary clinical and commercial focus is on natural functional substances such as N-acetylglucosamine for joint and skin health, and anserine for the reduction of uric acid and fatigue. The company has successfully commercialized several bioactive compounds with clinically backed benefits for osteoarthritis and metabolic health.

Therapeutic areas: NeurologyRheumatologyDermatologyMetabolic Disorders
Modalities: Small moleculePeptidesNatural product extracts
Industry: Food & Nutrition

Partnerships

Sanyo ShokuhinNissui

Beyond the preview

Go deeper on Yaizu Suisankagaku Industry.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yaizu Suisankagaku Industry.

Explore the full profile